10,035 Shares in Agilent Technologies, Inc. (NYSE:A) Purchased by University of Texas Texas AM Investment Management Co.

Key Points

• The University of Texas Texas AM Investment Management Co. has made a new investment in Agilent Technologies, Inc. worth approximately $1.17 million, acquiring 10,035 shares in the first quarter.
• Agilent Technologies reported a quarterly earnings per share (EPS) of $1.31, exceeding analysts' expectations of $1.26, alongside revenues of $1.67 billion, up 6% from the previous year.
• The company recently announced a quarterly dividend of $0.248 per share, reflecting an annualized dividend of $0.99 and a dividend yield of 0.83%.

University of Texas Texas AM Investment Management Co. purchased a new position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 10,035 shares of the medical research company's stock, valued at approximately $1,174,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in A. CIBC Private Wealth Group LLC lifted its position in shares of Agilent Technologies by 1.2% during the fourth quarter. CIBC Private Wealth Group LLC now owns 7,479 shares of the medical research company's stock worth $1,025,000 after purchasing an additional 87 shares in the last quarter. Valeo Financial Advisors LLC increased its position in Agilent Technologies by 3.0% in the 1st quarter. Valeo Financial Advisors LLC now owns 3,449 shares of the medical research company's stock valued at $403,000 after acquiring an additional 102 shares during the period. Western Pacific Wealth Management LP increased its position in Agilent Technologies by 15.2% in the 1st quarter. Western Pacific Wealth Management LP now owns 873 shares of the medical research company's stock valued at $102,000 after acquiring an additional 115 shares during the period. Bartlett & CO. Wealth Management LLC increased its holdings in shares of Agilent Technologies by 5.1% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,406 shares of the medical research company's stock valued at $281,000 after purchasing an additional 116 shares during the period. Finally, Brighton Jones LLC increased its holdings in shares of Agilent Technologies by 2.6% in the first quarter. Brighton Jones LLC now owns 4,784 shares of the medical research company's stock valued at $560,000 after purchasing an additional 121 shares during the period.

Wall Street Analyst Weigh In

A has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. dropped their price objective on Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a report on Thursday, May 29th. Robert W. Baird lowered their price target on shares of Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating on the stock in a research note on Thursday, May 22nd. Evercore ISI upped their target price on shares of Agilent Technologies from $125.00 to $130.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 8th. Jefferies Financial Group lowered their price target on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a report on Monday, April 21st. Finally, Leerink Partners increased their price target on shares of Agilent Technologies to $135.00 and gave the company a "buy" rating in a research report on Friday, May 30th. Six equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $139.77.

Agilent Technologies Stock Down 1.0%

Shares of NYSE:A traded down $1.14 during trading on Thursday, hitting $116.91. The company's stock had a trading volume of 730,164 shares, compared to its average volume of 2,019,976. The stock's 50-day moving average price is $116.88 and its two-hundred day moving average price is $121.18. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The company has a market capitalization of $33.21 billion, a PE ratio of 28.87, a PEG ratio of 3.64 and a beta of 1.23. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.60 and a current ratio of 2.09.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.26 by $0.05. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.63 billion. During the same quarter last year, the business earned $1.22 earnings per share. Agilent Technologies's revenue was up 6.0% compared to the same quarter last year. As a group, sell-side analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, July 23rd. Stockholders of record on Tuesday, July 1st were given a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.85%. The ex-dividend date of this dividend was Tuesday, July 1st. Agilent Technologies's dividend payout ratio (DPR) is currently 24.44%.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,508 shares of the business's stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the sale, the chief executive officer owned 37,448 shares of the company's stock, valued at approximately $4,397,893.12. The trade was a 3.87% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.